Total Payments
$1,696
2024 Payments
$356.65
Companies
16
Transactions
48
Medicare Patients
4,388
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$1,370 (80.8%)
Gifts$265.20 (15.6%)
Education$61.20 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,370 | 46 | 80.8% |
| Gift | $265.20 | 1 | 15.6% |
| Education | $61.20 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Veloxis Pharmaceuticals, Inc. | $373.25 | 13 | $0 (2024) |
| NxThera, Inc. | $269.76 | 2 | $0 (2018) |
| AbbVie, Inc. | $267.31 | 4 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $217.53 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $142.41 | 3 | $0 (2024) |
| Kyowa Kirin, Inc. | $86.88 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $79.05 | 2 | $0 (2019) |
| Alnylam Pharmaceuticals Inc. | $56.76 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $40.39 | 3 | $0 (2019) |
| Blue Earth Diagnostics Limited | $32.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $356.65 | 11 | E.R. Squibb & Sons, L.L.C. ($126.05) |
| 2023 | $260.32 | 9 | Veloxis Pharmaceuticals, Inc. ($100.08) |
| 2022 | $73.07 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($48.73) |
| 2021 | $18.74 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($18.74) |
| 2020 | $184.51 | 6 | Veloxis Pharmaceuticals, Inc. ($160.35) |
| 2019 | $188.20 | 8 | Otsuka America Pharmaceutical, Inc. ($61.20) |
| 2018 | $275.17 | 5 | AbbVie, Inc. ($254.80) |
| 2017 | $339.43 | 5 | NxThera, Inc. ($265.20) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: TRANSPLANTATION | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $110.33 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: TRANSPLANTATION | ||||||
| 07/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 04/30/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 04/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Oncology | ||||||
| 12/18/2023 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 12/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: TRANSPLANTATION | ||||||
| 09/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: TRANSPLANTATION | ||||||
| 06/17/2023 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: TRANSPLANTATION | ||||||
| 06/16/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: Genetic Disease | ||||||
| 02/10/2023 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Genetic Disease | ||||||
| 01/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Nephrology | ||||||
| 08/12/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $18.74 | General |
| 11/11/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $26.53 | General |
| Category: Immunosuppressant | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,045 | 1,543 | $924,590 | $318,248 |
| 2022 | 15 | 907 | 1,339 | $719,130 | $257,779 |
| 2021 | 18 | 1,216 | 2,182 | $789,885 | $290,942 |
| 2020 | 16 | 1,220 | 2,163 | $664,385 | $232,640 |
Total Patients
4,388
Total Services
7,227
Medicare Billing
$1.1M
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50360 | Transplantation of donor kidney | Facility | 2023 | 72 | 72 | $374,400 | $145,102 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 438 | $109,500 | $47,634 | 43.5% |
| 50605 | Insertion of stent in ureter | Facility | 2023 | 71 | 71 | $163,300 | $29,857 | 18.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 162 | 195 | $63,375 | $29,483 | 46.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 92 | 120 | $48,000 | $17,436 | 36.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 130 | $20,150 | $8,618 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 110 | $17,690 | $8,601 | 48.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 48 | 57 | $18,825 | $6,857 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 52 | $13,000 | $4,254 | 32.7% |
| 76776 | Ultrasound scan of transplanted kidney | Office | 2023 | 26 | 31 | $12,865 | $4,242 | 33.0% |
| 50327 | Preparation of donor kidney and veins for transplantation | Facility | 2023 | 36 | 36 | $21,600 | $3,330 | 15.4% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2023 | 38 | 39 | $23,400 | $3,327 | 14.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 53 | 57 | $8,550 | $2,611 | 30.5% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 34 | 45 | $11,250 | $1,955 | 17.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 25 | 25 | $4,000 | $1,708 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 29 | $4,730 | $1,605 | 33.9% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 13 | 19 | $6,555 | $1,006 | 15.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 14 | 17 | $3,400 | $621.35 | 18.3% |
| 50360 | Transplantation of donor kidney | Facility | 2022 | 50 | 50 | $260,000 | $101,061 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 287 | 553 | $138,250 | $60,526 | 43.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 130 | 157 | $51,025 | $23,724 | 46.5% |
| 50605 | Insertion of stent in ureter | Facility | 2022 | 46 | 46 | $105,800 | $19,589 | 18.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 89 | 106 | $42,400 | $18,210 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 127 | $20,320 | $9,841 | 48.4% |
| 76776 | Ultrasound scan of transplanted kidney | Office | 2022 | 36 | 47 | $19,505 | $6,289 | 32.2% |
About Dr. Robert Naraghi, M.D
Dr. Robert Naraghi, M.D is a Specialist healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306950043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Naraghi, M.D has received a total of $1,696 in payments from pharmaceutical and medical device companies, with $356.65 received in 2024. These payments were reported across 48 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,370).
As a Medicare-enrolled provider, Naraghi has provided services to 4,388 Medicare beneficiaries, totaling 7,227 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Urology
- Location Orange, CA
- Active Since 08/19/2006
- Last Updated 06/25/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1306950043
Products in Payments
- Rezum (Device) $269.76
- Mavyret (Drug) $267.31
- LIVTENCITY (Drug) $198.79
- Envarsus (Drug) $198.55
- ENVARSUS (Drug) $147.69
- NULOJIX (Biological) $126.05
- Crysvita (Drug) $86.88
- SAMSCA (Drug) $79.05
- OXLUMO (Drug) $56.76
- Erleada (Drug) $40.39
- Axumin (Drug) $32.00
- PREVYMIS (Drug) $30.84
- TARPEYO (Drug) $24.34
- LOKELMA (Drug) $24.16
- BOTOX (Drug) $19.54
- Cologuard Collection Kit (Device) $18.69
- OPDIVO (Biological) $16.36
- Envarsus XR (SP) (Drug) $15.81
- ZORTRESS (Drug) $13.18
- Envarsus XR (Drug) $11.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Orange
Andrew Cassidenti, M.d, M.D
Specialist — Payments: $83,590
Specialist $83,590
Dr. Steve Mora, M.d, M.D
Specialist — Payments: $54,129
Specialist $54,129
Dr. Brian Palafox, M.d, M.D
Specialist — Payments: $53,229
Specialist $53,229
Dr. Samuel Rosenfeld, M.d, M.D
Specialist — Payments: $47,823
Specialist $47,823
Dr. Thomas Kim, M.d, M.D
Specialist — Payments: $47,716
Specialist $47,716
Gerald Alexander, M.d, M.D
Specialist — Payments: $45,760
Specialist $45,760